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Introduction
In different studies, use if diuretics have been shown not
useful for AKI prevention and a possible relationship
with mortality has been suggested.
Objectives
We intend to analyze this issue by means of propensity
score methodology (PS).
Methods
Post-hoc analysis of a prospective observational cohort
from a previous study on AKI conducted in our Unit.
We defined AKI based in KDIGO II/III stages criteria.
We calculated a PS for patients with or without diure-
tics by regression analysis and pairing 1:1 by quintiles
grouping. Then performed an analysis for diuretic-AKI
and diuretic-mortality by logistic regression, including
the PS in it. Software R 3.1.2 para OsX. The Ethics
Committee from our centre approved this work.
Results
from 279 patients studied, 80 out of 142 patients with
diuretic (56.3%) developed AKI against 56 out of 137
(41.2%) without it (p < 0.01), OR 1.86 (IC 1.16-3.01).
We computed a PS adjusting by age, gender, history of
high blood pressure, diagnosis, basal creatinine and
vasopressors. After the pairing an optimal balance was
not reached for gender, diagnosis and base creatinine
and these variables were included beside PS in the final
logistic regression analysis. In this regression we did not
detect any significant effect of the diuretic on AKI
development, OR 1.26 (IC 95% 0.73-2.18).
Among patients without diuretic, mortality was 47.4%
against 61.4% when diuretic was used (p < 0.001), OR
5.07 (IC 95% 2.89-8.86), absolute mortality difference
37.9% (IC 25.8-50.1). We computed a PS adjusting by
age, diagnosis, APACHE, basal creatinine, infection and
vasopressors. After the pairing an optimal balance was
not reached for APACHE, infection and base creatinine
and these variables were included beside PS in the final
logistic regression analysis. In the final analysis, diuretic
use retained a significant relationship with mortality, OR
3.26 (IC 95% 1.78-5.97).
Conclusions
In our cohort, once confounding variables were con-
trolled by propensity score methodology, diuretic use
did not relate to AKI development but showed an inde-
pendent relationship with hospital mortality.
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